A top executive at Swiss drug giant Novartis told us the inside story of the $2.1 million price tag for the most expensive drug in the world (NVS)

The FDA just approved a cutting-edge new treatment from Swiss drug giant Novartis for a rare genetic disease called spinal muscular atrophy. Priced at $2.1 million, it is the world’s most expensive drug. We spoke with Dave Lennon, the head of the Novartis unit that makes the drug, about how the drugmaker decided on its price tag.  Lennon acknowledged the “sticker shock” of this price point but said that because of how expensive this

Continue reading...